Privia Health Group, Inc.
NASDAQ:PRVA
21.84 (USD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 437.921 | 422.326 | 415.243 | 440.828 | 417.282 | 413.351 | 386.276 | 364.424 | 342.899 | 335.536 | 313.801 | 275.333 | 251.524 | 225.756 | 213.607 | 213.699 | 207.17 | 183.264 | 212.942 |
| Cost of Revenue
| 0 | 381.46 | 376.214 | 403.559 | 375.546 | 371.918 | 346.985 | 327.711 | 309.013 | 301.695 | 283.459 | 250.446 | 225.369 | 238.668 | 188.075 | 190.301 | 185.673 | 165.852 | 192.667 |
| Gross Profit
| 437.921 | 40.866 | 39.029 | 37.269 | 41.736 | 41.433 | 39.291 | 36.713 | 33.886 | 33.841 | 30.342 | 24.887 | 26.155 | -12.912 | 25.532 | 23.398 | 21.497 | 17.412 | 20.275 |
| Gross Profit Ratio
| 1 | 0.097 | 0.094 | 0.085 | 0.1 | 0.1 | 0.102 | 0.101 | 0.099 | 0.101 | 0.097 | 0.09 | 0.104 | -0.057 | 0.12 | 0.109 | 0.104 | 0.095 | 0.095 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 30.695 | 28.916 | 32.121 | 29.6 | 27.228 | 26.808 | 25.951 | 28.156 | 32.219 | 33.107 | 36.11 | 39.321 | 33.91 | 168.657 | 13.996 | 14.82 | 9.788 | 8.419 | 10.989 |
| Selling & Marketing Expenses
| 7.047 | 6.852 | 6.085 | 6.249 | 7.241 | 5.956 | 5.286 | 5.173 | 5.088 | 4.819 | 4.661 | 3.8 | 4.588 | 11.178 | 3.184 | 3.962 | 2.709 | 2.22 | 2.452 |
| SG&A
| 37.742 | 35.768 | 38.206 | 35.849 | 34.469 | 32.764 | 31.237 | 33.329 | 37.307 | 37.926 | 40.771 | 43.121 | 38.498 | 179.835 | 17.18 | 18.782 | 12.497 | 10.639 | 13.441 |
| Other Expenses
| 394.366 | 381.46 | 376.214 | 403,559 | 377.277 | 373.608 | 1.34 | 1.135 | 1.153 | 302.86 | 1.118 | 1.113 | 0.466 | 0.44 | 0.445 | 0.454 | 0.457 | 0.594 | 0.338 |
| Operating Expenses
| 432.108 | 35.768 | 38.206 | 35.849 | 36.2 | 34.454 | 32.577 | 34.464 | 38.46 | 39.091 | 41.889 | 44.234 | 38.964 | 180.275 | 17.625 | 19.236 | 12.954 | 11.233 | 13.779 |
| Operating Income
| 5.813 | 5.098 | 0.823 | 1.42 | 5.536 | 6.979 | 6.714 | 2.249 | -4.574 | -5.25 | -11.547 | -19.347 | -12.809 | -193.187 | 7.907 | 4.162 | 8.543 | 6.179 | 6.496 |
| Operating Income Ratio
| 0.013 | 0.012 | 0.002 | 0.003 | 0.013 | 0.017 | 0.017 | 0.006 | -0.013 | -0.016 | -0.037 | -0.07 | -0.051 | -0.856 | 0.037 | 0.019 | 0.041 | 0.034 | 0.031 |
| Total Other Income Expenses Net
| 2.164 | 2.966 | 2.984 | 2.848 | 2.894 | 0.817 | 1.813 | 1.152 | 0.285 | -0.663 | -0.232 | -0.185 | -0.292 | -0.302 | -0.291 | -0.437 | -0.504 | -0.509 | -0.467 |
| Income Before Tax
| 7.977 | 8.064 | 3.807 | 4.268 | 8.43 | 7.796 | 8.527 | 3.401 | -4.289 | -5.913 | -11.779 | -19.532 | -13.101 | -193.489 | 7.616 | 3.725 | 8.039 | 5.67 | 6.029 |
| Income Before Tax Ratio
| 0.018 | 0.019 | 0.009 | 0.01 | 0.02 | 0.019 | 0.022 | 0.009 | -0.013 | -0.018 | -0.038 | -0.071 | -0.052 | -0.857 | 0.036 | 0.017 | 0.039 | 0.031 | 0.028 |
| Income Tax Expense
| 3.999 | 3.421 | 0.751 | 1.944 | 2.488 | 1.436 | 2.125 | -13.447 | -4.845 | 5.468 | 6.308 | -7.643 | -2.21 | -20.004 | 2 | -0.054 | -8.561 | 0.474 | 0.7 |
| Net Income
| 3.535 | 3.467 | 2.984 | 2.838 | 5.643 | 7.274 | 7.324 | 17.776 | 0.556 | -10.475 | -18.087 | -11.979 | -9.115 | -172.534 | 5.398 | 3.864 | 16.685 | 5.281 | 5.414 |
| Net Income Ratio
| 0.008 | 0.008 | 0.007 | 0.006 | 0.014 | 0.018 | 0.019 | 0.049 | 0.002 | -0.031 | -0.058 | -0.044 | -0.036 | -0.764 | 0.025 | 0.018 | 0.081 | 0.029 | 0.025 |
| EPS
| 0.03 | 0.029 | 0.025 | 0.024 | 0.048 | 0.063 | 0.064 | 0.16 | 0.005 | -0.096 | -0.17 | -0.11 | -0.09 | -1.68 | 0.052 | 0.038 | 0.16 | 0.051 | 0.053 |
| EPS Diluted
| 0.028 | 0.028 | 0.024 | 0.023 | 0.045 | 0.058 | 0.059 | 0.14 | 0.005 | -0.096 | -0.17 | -0.11 | -0.086 | -1.68 | 0.052 | 0.038 | 0.16 | 0.051 | 0.053 |
| EBITDA
| 9.331 | 6.916 | 2.644 | 3.192 | 7.267 | 8.669 | 8.054 | 3.384 | -3.421 | -4.085 | -10.429 | -18.234 | -12.342 | -192.747 | 8.352 | 4.616 | 9.001 | 6.773 | 6.834 |
| EBITDA Ratio
| 0.021 | 0.016 | 0.006 | 0.007 | 0.017 | 0.021 | 0.021 | 0.009 | -0.01 | -0.012 | -0.033 | -0.066 | -0.049 | -0.854 | 0.039 | 0.022 | 0.043 | 0.037 | 0.032 |